跳至主要内容
临床试验/NL-OMON25167
NL-OMON25167已完成不适用

A double-blind, randomized, double dummy, cross over, study to assess the difference in efficacy between nebulisation of rhDNase before airway clearande therapy (ACT)versus nebulisation after ACT.

Roche Nederland BVPO box 443440 AA WOERDEN The Netherlands0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25

研究概览

简要总结

Pediatr Pulmonol. 2007 Jul;42(7):624-30.

Eur Respir J. 2007 Oct;30(4):763-8. Epub 2007 Jun 27.

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Proven CF, as evidenced by an abnormal sweat test or an abnormal rectum potential difference measurement or by the presence of two CF mutations and at least one clinical feature of CF;
  • 2. Treated at the Erasmus MC - Sophia, and

排除标准

  • 1. Using rhDNase more than once daily;
  • 2. Mental retardation;

研究者

发起方
Roche Nederland BVPO box 443440 AA WOERDEN The Netherlands

相似试验